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Abstract
Objective—This systematic narrative review examined the empirical evidence on the 
effectiveness of mobile health (mHealth) behavioral interventions designed to increase uptake of 
HIV testing among vulnerable and key populations.
Methods—MEDLINE/PubMed, Embase, Web of Science, and Global Health electronic 
databases were searched. Studies were eligible for inclusion if they were published between 2005 
and 2015, evaluated an mHealth intervention, and reported an outcome relating to HIV testing. We 
also reviewed the bibliographies of retrieved studies for other relevant citations. The 
methodological rigor of selected articles was assessed, and narrative analyses were used to 
synthesize findings from mixed methodologies.
Results—A total of seven articles met the inclusion criteria. Most mHealth interventions 
employed a text-messaging feature and were conducted in middle- and high-income countries. The 
methodological rigor was moderate among studies. The current literature suggests that mHealth 
interventions can have significant positive effects on HIV testing initiation among vulnerable and 
key populations, as well as the general public. In some cases, null results were observed. 
Qualitative themes relating to use of mobile technologies to increase HIV testing included the 
benefits of having low-cost, confidential, and motivational communication. Reported barriers 
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included cellular network restrictions, poor linkages with physical testing services, and limited 
knowledge of appropriate text-messaging dose.
Conclusions—MHealth interventions may prove beneficial in reducing the proportion of 
undiagnosed persons living with HIV, particularly among vulnerable and key populations. 
However, more rigorous and tailored intervention trials are needed to assess the effectiveness of 
widespread use.
Introduction
Despite prevention successes in scaling up HIV testing services (HTS), the Joint United 
Nations Programme on HIV/AIDS (UNAIDS) estimates that roughly half of people infected 
with HIV in the world are unaware of their HIV status as a result of insufficient levels of 
HIV testing in populations most at risk of HIV (1–3). Knowledge of one’s HIV status is a 
crucial step in accessing HIV care and initiating antiretroviral therapies early, which has 
been shown to reduce transmission of HIV (4). Learning that one is infected with HIV can 
also lead to reductions in sexual risk behaviors, such as inconsistent condom use and 
multiple sexual partners which contribute to the spread of the virus (5–13). However, there 
are several barriers to HIV testing, including fear of negative consequences, discrimination, 
and perceived low risk of acquiring HIV, as well as lack of knowledge regarding free or low-
cost testing and treatment options (14–18). Other barriers to HIV testing include fear of 
breaches in confidentiality at testing sites, test costs, and uncertainty about where to go for 
testing (19–21). Individuals seeking HTS may also remain unaware of their status if return 
visits are not completed (22). As new UNAIDS goals seek to ensure that 90% of all people 
with HIV are diagnosed by 2020, innovative interventions are needed to improve uptake of 
HTS (2).
Mobile health (mHealth) strategies representing use of mobile technologies, such as mobile 
phones, personal digital assistants, and other wireless devices to support medical and public 
health practice, can be an innovative approach to increase HIV testing rates (23–25). There 
are approximately 5 billion mobile phone subscriptions in the world (26). Because such a 
large number of individuals use mobile phones, mHealth behavioral interventions have been 
implemented and evaluated in low- and middle-income countries to improve HIV care 
outcomes relating to antiretroviral initiation and adherence (27–30).
MHealth interventions may also hold promise for increasing awareness and initiation of HIV 
testing (25), particularly among high-risk populations, such as vulnerable and key 
populations with high rates of not yet diagnosed HIV infection (1). As mobile phone text 
messaging has been shown to promote patient-physician communication, text messages 
providing information on HIV testing may encourage high-risk individuals to seek 
community or clinic-based HTS (23, 25, 31). Mobile phone text messaging may also be an 
effective tool to improve HIV testing self-efficacy given that information can be 
personalized and interactive (23). Previous reviews (32–38) have examined use of mobile 
phone technologies in HIV prevention and treatment, but have not specifically examined the 
effectiveness of mHealth interventions on uptake of HIV testing. As a result, questions 
remain about the unique capacity of mobile technologies to improve testing rates among 
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populations most-at-risk for HIV. To answer this question, this systematic narrative review 
examined the current literature of mHealth interventions aimed at increasing HIV testing 
with a specific focus on vulnerable and key populations. We discuss the evidence to-date and 
implications for future research and practice.
Methods
Search Process
MEDLINE/PubMed, Embase, Web of Science, and Global Health electronic databases were 
searched to identify manuscripts evaluating HIV testing mHealth strategies in biomedical 
and social science databases. These databases were selected to cover a wide range of 
disciplines, from social sciences to interdisciplinary to biomedical research. A combination 
of search terms relating to mobile phones, testing, and HIV were used [Table 1]. We also 
reviewed the bibliographies of retrieved full text studies for other relevant citations.
Inclusion Criteria
Studies were eligible for inclusion if they were: (i) an evaluation of a behavioral intervention 
using mobile technology (i.e., text messaging, calls, mobile web, or mobile apps) either as a 
component or stand-alone strategy; (ii) reported an outcome relating to uptake of HIV 
testing; (iii) available in the English language; and (iv) published between January 1, 2005 
and August 1, 2015. We excluded internet-based, online, and social media interventions that 
were not mobile-based strategies, as well as conference abstracts and posters. In addition, 
given the expansion of rapid screening tests and the imperative to target individuals with 
unknown serostatus (1, 39, 40), we only included articles examining mobile technologies to 
improve HIV test initiation which we defined as the first test encounter by an individual to 
determine HIV serostatus (1). We excluded studies examining mobile technologies to 
improve test turnaround times, clinic returns for test results, or notification of test results. 
Studies targeting HTS for all ages and in all settings were eligible for inclusion.
Full Text Review
All articles were initially screened by two reviewers who independently examined the titles 
and abstracts of studies to accept or reject for full text review. The same two reviewers then 
independently reviewed the full text articles to confirm eligibility. Data were extracted from 
eligible studies relating to the following characteristics: author, year, country, intervention 
objective, mobile phone type, non-mobile components, study design, participant sample, 
effectiveness on HIV testing, and author mHealth recommendations. A quality assessment 
was conducted for each article based on published guidelines for assessing the rigor and risk 
of bias in research studies (41–44). Findings were interpreted and discussed taking into 
account the study design. In order to examine all literature, no studies were excluded based 
on quality assessments.
Analysis
We conducted a narrative analysis, summarizing quantitative and qualitative evidence, of the 
studies given the broad range of intervention strategies, target groups, and outcome measures 
for test initiation. Narrative analyses are appropriate for reviews involving mixed 
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methodologies (45, 46). In addition to summarizing reported quantitative changes, we used 
an inductive approach to identify qualitative themes on effectiveness of implementation 
across three target populations which we defined as: (i) vulnerable populations, representing 
individuals which a high burden of and/or risk of exposure to HIV, such as pregnant women, 
racial and ethnic minorities, displaced persons, as well as children and sexual partners 
exposed to HIV (47–49); (ii) key populations, representing individuals most-at-risk for HIV, 
such as injection drug users, MSM, incarcerated persons, transgender people, and sex 
workers (1); and (iii) general populations, including interventions targeting the broad public 
(not specifically vulnerable or key populations) within a defined geographic region. We read 
each article several times and coded findings that were then consolidated into larger themes.
Results
Selected Articles
We retrieved 23 full-text articles from 564 potentially relevant citations based on review of 
the article’s title and abstract (Figure 1). Following a full-text review for eligibility, 7 articles 
were retained for analysis: Agarwal 2015 (50), Bourne 2011 (51), Burton 2013 (52), de 
Tolly 2012 (53), Odeny 2014 (54), Udeagu 2014 (55), and Zou 2013 (56). The majority of 
studies utilized mobile phone text-messaging (or short message service, SMS) and calling 
features to target HIV testing (Table 2). There was considerable variation in type of indicator 
and assessment durations used (Table 3). Several studies relied on quasi-experimental 
designs with risks of biases relating to follow-up and outcome assessments (Table 4). Two 
studies utilized qualitative methods and reported verbatim textual data to confirm their 
findings.
Vulnerable Populations
Two of the seven selected articles targeted vulnerable populations. A randomized controlled 
trial (RCT) in Kenya compared the proportion of HIV-positive mothers (n=388) returning to 
clinic for virological infant HIV testing at 8 weeks postpartum among women receiving 14 
HIV-neutral infant immunization SMS messages compared to HIV-positive women in usual 
care (no SMS) (54) (Table 3). HIV infant testing was significantly higher among SMS-
messaged women (92%) as compared to non-messaged women (85%, p<0.05; OR=1.08, 
95% CI:1.00–1.16) (54). The second intervention was developed for sex partners of recently 
HIV-diagnosed patients (n=3,247) in the United States (55). This quasi-experimental study 
examined the proportion of HIV-exposed sex partners with negative or unknown serostatus 
who, in turn, underwent HIV testing. Results showed that HIV testing among sex partners 
was significantly lower in those receiving text-messaged partner notification (PNS) services 
(45%) compared to traditional PN services (i.e., postal mail, landline calls, field visits) 
(69%, p<0.0001) and no different in comparison to internet-based PN services (34%, 
OR=0.7, 95% CI:0.40–1.50) (55).
Key Populations
Four studies were dedicated to key populations, usually MSM. Three studies evaluated 
stand-alone mobile phone health interventions, although they were limited by selection 
biases from non-randomized trial designs. Among MSM who had undergone an initial HIV 
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test (n=1,753), a quasi-experimental trial in Australia compared the proportion of repeat 
HIV testing among those receiving a 4-month SMS reminder compared to MSM who did 
not receive the reminder (51) (Table 3). Over half (64%) of text-messaged MSM clients 
initiated a second test in the nine months prior compared to non-messaged MSM (30%, 
p<0.001), and they were 4.3 times more likely to do so (OR=4.3, 95% CI:3.5, 5.2) (51).
In a single-group post-intervention assessment in India, the authors qualitatively reported 
that a small proportion (no statistics provided) of MSM who called into an MSM-dedicated 
helpline reported getting an HIV test due to the helpline’s referral compared to 30% of 
MSM callers who had been tested for HIV at baseline (50). The MSM helpline was 
accessible daily, all-day, and provided information on HIV prevention and testing with the 
option of phoning a counselor, listening to an interactive voice response (IVR), or receiving 
an SMS (50). Another intervention in the United Kingdom sent SMS reminders to sexual 
health clinic attendees (n=539) at high risk for HIV approximately 2 to 12 weeks following 
their initial visit, targeting key populations (MSM patients and commercial sex workers) as 
well as vulnerable populations (women receiving emergency contraception and persons with 
prior STI diagnosis) (52). Using a quasi-experimental design, the authors found no 
significant differences in the proportion of text-messaged (33%) versus non-messaged 
clients (35%, p>0.05) who returned for a repeat HIV/STI test in the following four months 
(52).
The fourth key populations’ intervention targeted adult MSM in China (n=3,332) and 
combined mobile phone calling with online outreach and financial incentives (56). This 
quasi-experimental trial identified MSM on gay partner-seeking websites and invited them 
for HIV testing using mobile phone, email, instant messaging, or chat room follow-up. 
Based on descriptive statistics, the percent attendance at local VCT clinics for HIV testing 
was higher for MSM invited for testing by mobile phone (8.3%) compared to those 
contacted by email (4.3%), but lower compared to MSM invited by instant message (11.5%) 
and chat room follow-up (20.1%) (56).
General Populations
One study in South Africa evaluated an intervention geared towards the general public. This 
RCT incorporated qualitative research methods and randomized mobile phone-competition 
subscribers (n=2,533) to one of four text-messaging conditions over the course of 4 to 8 
weeks to prompt HIV test-seeking (53). Mobile users receiving 10 motivational (MOTI) 
HCT texts were 70% more likely to report having tested for HIV (OR=1.70, 95% CI:1.19–
2.44) since the start of the intervention compared to control participants (no text messages) 
(53). However, no significant differences were observed for mobile users receiving 3 MOTI 
texts (OR=0.73, 95% CI:0.53–1.01), 10 informational texts (OR=1.05, 95%CI:0.77–1.44), 
or 3 informational texts (OR=0.92, 95% CI:0.66–1.27) as compared to control. Qualitative 
findings for non-HCT were lack of time, inaccessible testing sites, and fear of results.
Emerging Themes from Selected Articles
Several of the selected studies reported on the overall benefits of the mobile phone-based 
strategy in providing low-cost customizable and confidential communication (50, 51, 53, 
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54). One common theme was that mobile phone-strategies were more easily implementable 
by health care systems, provided that only minimal and low-literacy technology was used 
(55). However, despite introducing interventions within health systems, user costs to send 
and receive text messages were often prohibitive (53, 54). A second theme was that 
intervention effectiveness was sometimes hindered by telephone regulatory and 
infrastructural barriers. For example, Agarwal (50) found that fewer callers used the text-
message option compared to calls because text messages were not free and the service was 
blocked by “do not disturb” registrations. Bourne (51) also attributed lower use of SMS 
reminders by clinicians to their being separate from the electronic health record and 
therefore easy to omit.
A third theme related to the difficulty of linking mobile phone-based HTS messages or calls 
to HTS sites in geographical proximity of the user. For example, in India, while calls entered 
the helpline nationwide, the directory of HTS was available in only three states (50). 
Similarly in Australia, the authors noted that despite using a mobile phone strategy, 
measuring the effectiveness of the intervention required tracking HIV testing at physical 
sites, which was not always feasible (51). In South Africa and China, respectively, 
participants who received the HTS prompts also complained of having few testing sites 
available outside of normal business hours (53) or not knowing where HTS sites were 
located (56).
There were four less common themes. One was that mobile phone strategies should be 
testable for participants at various stages of use. For example, Agarwal (50) found that 
Indian users initially called the MSM hotline without speaking in order to confirm its 
confidentiality. A second less common theme related to the importance of intervention 
quality maintenance. For example, mystery callers with pre-determined questions were used 
in India to assess services received by MSM hotline callers (50). As a third less common 
theme, Burton (52) suggested that SMS reminders may have been more effective if they had 
come from a recognized clinic and had been more tailored and interactive for clients. 
Finally, being able to identify the minimally effective dosage of mobile content was also 
considered important (52–54).
Discussion
To our knowledge, this is the first narrative review to focus solely on use of mobile 
technologies to improve uptake of HIV testing. Despite a proliferation of mHealth strategies 
geared towards HIV, we identified a relatively small number of studies targeting initiation of 
testing in not yet diagnosed individuals. Among these, more than half of the studies reported 
a significant increase in HIV testing as a result of mobile phone stand-alone and integrated 
strategies (51, 53, 54, 56). Positive effects on HIV test initiation were observed among 
mHealth interventions in vulnerable (54), key (51, 56), and general populations (53), 
although not all high-risk sub-groups were included. Our review did not identify mHealth 
HIV testing interventions addressing test gaps among injection drug users, transgender 
individuals, or homeless youth who are all disproportionately infected. Reaching the 
UNAIDS goal of 90% diagnosis of all persons with HIV may be enhanced by leveraging 
mobile technologies to improve uptake of HTS for all high-risk populations.
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Several implications emerged from this review. One relates to the geographic emphasis of 
mHealth testing interventions. Despite the high burden of HIV, low uptake of HTS, and high 
access to mobile phones in sub-Saharan Africa (57, 58), the majority of applicable studies 
were conducted in middle- and high-income countries. However, the only two African 
studies found that mobile-based HIV testing initiatives can be delivered successfully within 
the region with reported significant positive outcomes. This suggests that more efforts are 
needed to test and scale-up mHealth HIV testing initiatives in African settings.
Another implication relates specifically to use of text messages to increase HIV testing 
uptake, as this was the most common mHealth delivery mode. Several studies relied on text 
messages to encourage HIV testing among targeted groups, although only one study 
examined the comparative effectiveness of various types of text-messaged formats (53). 
Previous research has suggested that motivational text messages can be used to address 
barriers to testing uptake, such as fear of knowing one’s status or lack of knowledge 
regarding the HIV testing process (59). Studies have also suggested that timing and 
frequency of tailored text messaging can significantly impact outcomes (53, 60, 61). 
Findings from this review indicate that less is known regarding the optimum format and 
frequency of text messages to address low rates of HIV testing as most studies evaluated 
only one strategy. As more mHealth intervention rely on text messages to reach undiagnosed 
persons with HIV, it will be critical to tailor mobile content and delivery to local needs and 
understand factors that may influence the effectiveness of text-based promotion of HTS.
Of important note is the interpretation of the mixed and null results observed in this review. 
In some cases, mobile phone-based interventions were less effective in increasing HIV test 
initiation as compared to online strategies or in-person usual care conditions. These findings 
imply that the ability of mobile health technologies to increase HIV test initiation in all 
populations may be limited, particularly among individuals who prefer health 
communication via online, in-person, or social media networks. We also observed among 
studies that some barriers to HIV test initiation, such as stigma, inconvenient HTS hours, 
and cellular network restrictions were less amenable to text-messaged approaches and may 
benefit from broader mHealth inputs.
More rigorous study designs are needed to fully assess the effectiveness of mobile phone 
strategies on uptake of HIV testing, building on attributes of quantitative and qualitative 
research methods. Our findings were limited by the quality of available studies which 
included several single-group and quasi-experimental designs. Therefore, the review’s 
findings should be considered with this in mind. Interpretation was also hindered by 
incomplete outcomes reporting (i.e., proportions, ratios). It was not always possible to 
distinguish between testing for HIV testing versus HIV and other STIs. Some authors 
reported also that measurement of HIV testing was limited by an inability to follow mHealth 
users to physical testing sites.
Nonetheless, this review provides a preliminary narrative on the potential of mHealth 
strategies to improve HIV testing in high prevalence settings in order to decrease the 
proportion of undiagnosed persons living with HIV. We found that mobile phone strategies 
were moderately effective among vulnerable and key populations, although more 
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information is needed to improve effectiveness of tailored text-messaged approaches and use 
of other mobile- and non-mobile intervention components to address low testing rates. 
Mobile network restrictions, potential insufficient dose, and preference for non-mobile HIV 
testing information remain as barriers to effective and widespread use.
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Figure 1. 
Summary of search results identifying potentially relevant, screened, and selected articles
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Table 1
Overview of search categories and terms
Electronic database MEDLINE/PubMed, Embase, Web of Science, Global Health
Search category Mobile [AND] Testing [AND] HIV
Search terms “mobile phone(s)“ OR “mobile devices“ OR 
“cell phone(s)“/[mesh] OR “cellular phone(s)” 
OR “smart phone(s)“ OR “smartphone(s)” OR 
“SMS“ OR “text“ OR “text messaging”/[mesh] 
OR “mHealth” OR “telemedicine”
“tested” OR “testing” OR 
“test(s)”
“human immunodeficiency 
virus“ OR “HIV” OR “STI” OR 
“sexually transmitted“ OR “acquired 
immunodeficiency syndrome“[mesh]
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